Learn the latest news about the CAT Facility and tips for learning flow cytometry. Feel free to share your opinion in the comments section of each post. The comment section will be moderated for tone and content.
We had Omar Abouzid from EasyPanel to discuss the new developments that comes with version 2. I've been pretty happy with the tool so far, but I'm now very excited to see how the new antibody inventory system will work out. The panel design tool itself has a few...
David Leclerc | Oct 30, 2023 | 0 Comments
The former Director of the CAT Facility, Ryan Duggan, had a good thing going with a Google Group in cytometry, before Google decided to shut down that tool. He was hosting Google hangouts, called Cytometry on Air, to discuss all things flow cytometry, which...
David Leclerc | Oct 14, 2023 | 0 Comments
Here's a quick note to showcase OMIPs, a library of optimized panels published in Cytometry part A. They are a collection of peer-reviewed multi-parameters panels that include a truckload of technical details. If you're looking for a shortcut in your panel design,...
David Leclerc | Oct 14, 2023 | 0 Comments
We recently launched a new YouTube channel to help us service our own equipment. You see, for the longest time, the CAT Facility has avoided purchasing service contracts for our equipment in order to make some very valuable savings. It does mean that the burden on...
David Leclerc | Oct 10, 2023 | 0 Comments
We're back from Madison where Everett and myself attended the GLIIFCA 2023 meeting. Mind you, I'm on the Board of Directors of that meeting so I'm a bit biased here. But it's a great meeting! It's only two days so the scientific content is distilled to its purest,...
David Leclerc | Sep 28, 2023 | 0 Comments
I had a discussion with our users about our cell sorters and the topic of the AriaII came up. It was removed from our roaster in 2022 and I realized I never explained what happened. Long story short, the AriaII was a victim of computer obsolescence. That sorter was...
David Leclerc | Aug 18, 2023 | 0 Comments
Get notified of new posts, opt out any time.
This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
